Amprenavir: A Review of its Clinical Potential in Patients with HIV Infection

ISSN： 0012-6667

Source： Drugs, Vol.60, Iss.6, 2000-12, pp. : 1383-1410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resistance to the HIV Protease Inhibitor Amprenavir In Vitro and in Clinical Studies: A Review

By Tisdale M. Myers R. Randall S. Maguire M. Ait-Khaled M. Elston R. Snowden W.

Clinical Drug Investigation, Vol. 20, Iss. 4, 2000-10 ,pp. : 267-285

Adis International

Access to resources Recommend Favorite

Raltegravir: A Review of its Use in the Management of HIV Infection in Treatment-Experienced Patients

By Croxtall Jamie D. Keam Susan J.

Drugs, Vol. 69, Iss. 8, 2009-06 ,pp. : 1059-1075

Adis International

Access to resources Recommend Favorite

Amprenavir or Fosamprenavir plus Ritonavir in HIV Infection: Pharmacology, Efficacy and Tolerability Profile

By Arvieux Cédric

Drugs, Vol. 65, Iss. 5, 2005-01 ,pp. : 633-659

Adis International

Access to resources Recommend Favorite

Piracetam: A Review of its Clinical Potential in the Management of Patients with Stroke

By Noble S. Benfield P.

CNS Drugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 497-511

Adis International

Access to resources Recommend Favorite

Vitamin D and HIV infection: a review of the clinical evidence

By Tafazoli Ali Khalili Hossein

Future Virology, Vol. 8, Iss. 6, 2013-06 ,pp. : 589-606

Future Medicine

Access to resources Recommend Favorite